Rocca S, Carra G, Poggio P, Morotti A, Brancaccio M
Mol Cancer. 2018; 17(1):40.
PMID: 29455651
PMC: 5817721.
DOI: 10.1186/s12943-018-0774-4.
Krombholz C, Aumann K, Kollek M, Bertele D, Fluhr S, Kunze M
Haematologica. 2016; 101(5):597-606.
PMID: 26888021
PMC: 5004370.
DOI: 10.3324/haematol.2015.138545.
Calvo K, Price S, Braylan R, Oliveira J, Lenardo M, Fleisher T
Blood. 2015; 125(18):2753-8.
PMID: 25691160
PMC: 4424627.
DOI: 10.1182/blood-2014-11-567917.
Niemeyer C, Loh M, Cseh A, Cooper T, Dvorak C, Chan R
Haematologica. 2015; 100(1):17-22.
PMID: 25552679
PMC: 4281308.
DOI: 10.3324/haematol.2014.109892.
Niemeyer C
Haematologica. 2014; 99(11):1653-62.
PMID: 25420281
PMC: 4222471.
DOI: 10.3324/haematol.2014.114595.
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia.
Hasegawa D, Bugarin C, Giordan M, Bresolin S, Longoni D, Micalizzi C
Blood Cancer J. 2013; 3:e160.
PMID: 24241400
PMC: 3880439.
DOI: 10.1038/bcj.2013.56.
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.
Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner J, MacMillan M
Blood. 2013; 122(12):2135-41.
PMID: 23926304
PMC: 3836039.
DOI: 10.1182/blood-2013-03-491589.
CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.
Javadi M, Richmond T, Huang K, Barber D
J Biol Chem. 2013; 288(27):19459-70.
PMID: 23696637
PMC: 3707649.
DOI: 10.1074/jbc.M113.475087.
N-ras mutation detection by pyrosequencing in adult patients with acute myeloid leukemia at a single institution.
Jeong J, Park S, Park M, Kim M, Kim K, Park P
Ann Lab Med. 2013; 33(3):159-66.
PMID: 23667841
PMC: 3646189.
DOI: 10.3343/alm.2013.33.3.159.
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
Driessen E, Van Roon E, Spijkers-Hagelstein J, Schneider P, De Lorenzo P, Valsecchi M
Haematologica. 2013; 98(6):937-44.
PMID: 23403319
PMC: 3669451.
DOI: 10.3324/haematol.2012.067983.
Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations.
Yoshida N, Doisaki S, Kojima S
Paediatr Drugs. 2012; 14(3):157-63.
PMID: 22480363
DOI: 10.2165/11631360-000000000-00000.
Genetic disruption of the PI3K regulatory subunits, p85α, p55α, and p50α, normalizes mutant PTPN11-induced hypersensitivity to GM-CSF.
Goodwin C, Yang Z, Yin F, Yu M, Chan R
Haematologica. 2012; 97(7):1042-7.
PMID: 22315502
PMC: 3396676.
DOI: 10.3324/haematol.2011.046896.
Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
Muramatsu H, Makishima H, Maciejewski J
Semin Oncol. 2012; 39(1):67-73.
PMID: 22289493
PMC: 3523950.
DOI: 10.1053/j.seminoncol.2011.11.004.
Gadd45 stress sensors in malignancy and leukemia.
Liebermann D, Tront J, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B
Crit Rev Oncog. 2011; 16(1-2):129-40.
PMID: 22150313
PMC: 3268054.
DOI: 10.1615/critrevoncog.v16.i1-2.120.
Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.
Xu J, Hedberg C, Dekker F, Li Q, Haigis K, Hwang E
Blood. 2011; 119(4):1032-5.
PMID: 22144181
PMC: 3271715.
DOI: 10.1182/blood-2011-06-358960.
Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis.
Liu X, Qu C
J Signal Transduct. 2011; 2011:195239.
PMID: 21799948
PMC: 3135119.
DOI: 10.1155/2011/195239.
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development.
Chung E, Kondo M
Immunol Res. 2010; 49(1-3):248-68.
PMID: 21170740
DOI: 10.1007/s12026-010-8187-5.
Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.
Yoshimi A, Kojima S, Hirano N
Paediatr Drugs. 2009; 12(1):11-21.
PMID: 20034338
DOI: 10.2165/11316200-000000000-00000.
Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational....
Raepple D, von Lintig F, Zemojtel T, Duchniewicz M, Jung A, Lubbert M
Ann Hematol. 2008; 88(4):319-24.
PMID: 18784923
PMC: 2755762.
DOI: 10.1007/s00277-008-0593-6.
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.
Chan R, Feng G
Blood. 2006; 109(3):862-7.
PMID: 17053061
PMC: 1785139.
DOI: 10.1182/blood-2006-07-028829.